SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) Conference on 7-8 October, showcasing at Booth 24, the Renaissance Boston Waterfront Hotel in Boston.

The company’s debut exhibit will feature a vast array of products that provide solutions for the growing demands in self-injection treatments. Displays include Needle Isolation Technology (NIT®) – a pre-attached needle mechanism for cartridge-based auto-injectors that eliminates the need for users to manually attach the needle or directly contact with the needle upon injection preparation; the refined Molly® variation – an auto-injector family that offers devices for drug fill volumes up to 2.25mL and is designed to be mass-produced effectively and efficiently.

Owning 30 years of experience and industry knowledge, SHL continues to thrive in the self-injection treatment space, offering pharma companies a broad scope of services that include the design, development and manufacturing of advanced drug delivery systems.

For more information on the event, or for the products and services SHL provide, please fill out the enquiry form attached to this page.